The ESMO Congress 2024 serves as a global platform for presenting and discussing groundbreaking translational cancer research, the first announcements of practice-changing data, and essential multidisciplinary conversations aimed at advancing transformative cancer therapies.
ESMO in the Alps offers a unique opportunity to delve deeper into these findings. The SAKK scientific committee thoroughly evaluated the results and their implications for clinical practice in Switzerland.

Discover the key takeaways from the SAKK event “ESMO in the Alps 2024,” held on September 25, 2024 in Lucerne.

Expert Statements highlight Promising Developments:

• Transform current standards of care
• Establish new standards of care
• Drive practice-changing advancements

This event is a key Event for SAKK, bringing the community together to shape a shared vision for the future. It provides a valuable perspective on how SAKK can continue to support clinical cancer research, ultimately aiming to achieve better outcomes for patients.

Take a moment to watch the video.